GlassScriptPhysician profile
Girish C Joshi
NPI 1316993728
$925.38
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $714 · 2020: $212.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $161.74 | 2019-2020 | |
| Lilly USA, LLC | $134.09 | 2019-2020 | |
| Glaxosmithkline, LLC. | $94.53 | 2019-2020 | |
| Novo Nordisk INC | $92.85 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $83.51 | 2019 | |
| Amgen INC. | $79.94 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.35 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.50 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.47 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $35.65 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $32.47 | 2020 | |
| Scilex Pharmaceuticals INC. | $20.00 | 2019 | |
| Seqirus USA INC | $19.84 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $16.75 | 2019 | |
| Sanofi Pasteur INC. | $15.69 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Girish Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.